Skip to main content
Top
Published in: Molecular Cancer 1/2014

Open Access 01-12-2014 | Research

NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction

Authors: Jun Ma, Jun Liu, Zhiming Wang, Xixi Gu, Yue Fan, Wen Zhang, Lili Xu, Jianjun Zhang, Dingfang Cai

Published in: Molecular Cancer | Issue 1/2014

Login to get access

Abstract

Overexpression of the proinflammatory cytokine IL-1β is associated with diverse diseases, including cancer. Alteration of microRNAs has been observed in cancer cells exposed to proinflammatory cytokines, yet their function in inflammation stress remains elusive. Here, we show that IL-1β induces the upregulation of miR-425, which negatively regulates phosphatase and tensin homolog expression by targeting its 3’ UTR. An increase in miR-425 depends on IL-1β-induced NF-kappaB activation, which enhances miR-425 gene transcription upon IL-1β induction. Consequently, repression of phosphatase and tensin homolog by miR-425 promotes gastric cancer cell proliferation, which is required to protect cells from cisplatin-induced apoptosis. Taken together, our data support a critical role for NF-kappaB-dependent upregulation of miR-425, which represents a new pathway for the repression of phosphatase and tensin homolog activation and the promotion of cell survival upon IL-1β induction.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107CrossRefPubMed
2.
go back to reference Fox JG, Rogers AB, Whary MT, Ge Z, Ohtani M, Jones EK, Wang TC: Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 −/− C57BL6 x Sv129 helicobacter pylori-infected mice. Am J Pathol. 2007, 171: 1520-1528. 10.2353/ajpath.2007.070249PubMedCentralCrossRefPubMed Fox JG, Rogers AB, Whary MT, Ge Z, Ohtani M, Jones EK, Wang TC: Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 −/− C57BL6 x Sv129 helicobacter pylori-infected mice. Am J Pathol. 2007, 171: 1520-1528. 10.2353/ajpath.2007.070249PubMedCentralCrossRefPubMed
3.
go back to reference Fox JG, Wang TC: Helicobacter pylori–not a good bug after all!. N Engl J Med. 2001, 345: 829-832. 10.1056/NEJM200109133451111CrossRefPubMed Fox JG, Wang TC: Helicobacter pylori–not a good bug after all!. N Engl J Med. 2001, 345: 829-832. 10.1056/NEJM200109133451111CrossRefPubMed
5.
go back to reference Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004, 431: 461-466. 10.1038/nature02924CrossRefPubMed Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004, 431: 461-466. 10.1038/nature02924CrossRefPubMed
6.
go back to reference Ben-Neriah Y, Karin M: Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol. 2011, 12: 715-723. 10.1038/ni.2060CrossRefPubMed Ben-Neriah Y, Karin M: Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol. 2011, 12: 715-723. 10.1038/ni.2060CrossRefPubMed
7.
go back to reference Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M: The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997, 91: 243-252. 10.1016/S0092-8674(00)80406-7CrossRefPubMed Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M: The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997, 91: 243-252. 10.1016/S0092-8674(00)80406-7CrossRefPubMed
8.
go back to reference Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009, 139: 693-706. 10.1016/j.cell.2009.10.014PubMedCentralCrossRefPubMed Iliopoulos D, Hirsch HA, Struhl K: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009, 139: 693-706. 10.1016/j.cell.2009.10.014PubMedCentralCrossRefPubMed
9.
go back to reference Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R: TRBP recruits the dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005, 436: 740-744. 10.1038/nature03868PubMedCentralCrossRefPubMed Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R: TRBP recruits the dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005, 436: 740-744. 10.1038/nature03868PubMedCentralCrossRefPubMed
10.
go back to reference Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, Chen WT: Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene. 2013, 32: 61-69. 10.1038/onc.2012.28CrossRefPubMed Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, Chen WT: Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene. 2013, 32: 61-69. 10.1038/onc.2012.28CrossRefPubMed
11.
go back to reference Brown RH: Medicine: a reinnervating microRNA. Science. 2009, 326: 1494-1495. 10.1126/science.1183842CrossRefPubMed Brown RH: Medicine: a reinnervating microRNA. Science. 2009, 326: 1494-1495. 10.1126/science.1183842CrossRefPubMed
12.
go back to reference Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF, Ge S: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene. Cancer. 2011, 117: 86-95. 10.1002/cncr.25522PubMedCentralCrossRefPubMed Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF, Ge S: Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene. Cancer. 2011, 117: 86-95. 10.1002/cncr.25522PubMedCentralCrossRefPubMed
13.
go back to reference Zhang J, Guo H, Qian G, Ge S, Ji H, Hu X, Chen W: MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer. 2010, 9: 211-PubMedCentralCrossRefPubMed Zhang J, Guo H, Qian G, Ge S, Ji H, Hu X, Chen W: MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer. 2010, 9: 211-PubMedCentralCrossRefPubMed
14.
15.
go back to reference Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM: Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 2013, 9: e1003311- 10.1371/journal.pgen.1003311PubMedCentralCrossRefPubMed Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM: Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 2013, 9: e1003311- 10.1371/journal.pgen.1003311PubMedCentralCrossRefPubMed
16.
go back to reference Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G: Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature. 2009, 461: 1084-1091. 10.1038/nature08486PubMedCentralCrossRefPubMed Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G: Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature. 2009, 461: 1084-1091. 10.1038/nature08486PubMedCentralCrossRefPubMed
17.
go back to reference Kasza A: IL-1 and EGF regulate expression of genes important in inflammation and cancer. Cytokine. 2013, 62: 22-33. 10.1016/j.cyto.2013.02.007CrossRefPubMed Kasza A: IL-1 and EGF regulate expression of genes important in inflammation and cancer. Cytokine. 2013, 62: 22-33. 10.1016/j.cyto.2013.02.007CrossRefPubMed
18.
go back to reference Roy D, Sarkar S, Felty Q: Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci. 2006, 11: 889-898. 10.2741/1845CrossRefPubMed Roy D, Sarkar S, Felty Q: Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci. 2006, 11: 889-898. 10.2741/1845CrossRefPubMed
19.
go back to reference Cebo C, Dambrouck T, Maes E, Laden C, Strecker G, Michalski JC, Zanetta JP: Recombinant human interleukins IL-1alpha, IL-1beta, IL-4, IL-6, and IL-7 show different and specific calcium-independent carbohydrate-binding properties. J Biol Chem. 2001, 276: 5685-5691. 10.1074/jbc.M008662200CrossRefPubMed Cebo C, Dambrouck T, Maes E, Laden C, Strecker G, Michalski JC, Zanetta JP: Recombinant human interleukins IL-1alpha, IL-1beta, IL-4, IL-6, and IL-7 show different and specific calcium-independent carbohydrate-binding properties. J Biol Chem. 2001, 276: 5685-5691. 10.1074/jbc.M008662200CrossRefPubMed
20.
go back to reference Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF: IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts. J Cell Biochem. 2010, 109: 975-982.PubMed Trebec-Reynolds DP, Voronov I, Heersche JN, Manolson MF: IL-1alpha and IL-1beta have different effects on formation and activity of large osteoclasts. J Cell Biochem. 2010, 109: 975-982.PubMed
21.
go back to reference Carmi Y, Dotan S, Rider P, Kaplanov I, White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN, Voronov E: The role of IL-1beta in the early tumor cell-induced angiogenic response. J Immunol. 2013, 190: 3500-3509. 10.4049/jimmunol.1202769CrossRefPubMed Carmi Y, Dotan S, Rider P, Kaplanov I, White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN, Voronov E: The role of IL-1beta in the early tumor cell-induced angiogenic response. J Immunol. 2013, 190: 3500-3509. 10.4049/jimmunol.1202769CrossRefPubMed
22.
go back to reference Zhang H: Anti-IL-1beta therapies. Recent Pat DNA Gene Seq. 2011, 5: 126-135. 10.2174/187221511796392024CrossRefPubMed Zhang H: Anti-IL-1beta therapies. Recent Pat DNA Gene Seq. 2011, 5: 126-135. 10.2174/187221511796392024CrossRefPubMed
23.
go back to reference Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S, Grady WM: Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene. 2013,  -doi: 10.1038/onc.2013.102 Yu M, Trobridge P, Wang Y, Kanngurn S, Morris SM, Knoblaugh S, Grady WM: Inactivation of TGF-beta signaling and loss of PTEN cooperate to induce colon cancer in vivo. Oncogene. 2013,  -doi: 10.1038/onc.2013.102
24.
go back to reference Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem. 1998, 273: 13375-13378. 10.1074/jbc.273.22.13375CrossRefPubMed Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem. 1998, 273: 13375-13378. 10.1074/jbc.273.22.13375CrossRefPubMed
25.
go back to reference Stocker H, Andjelkovic M, Oldham S, Laffargue M, Wymann MP, Hemmings BA, Hafen E: Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science. 2002, 295: 2088-2091. 10.1126/science.1068094CrossRefPubMed Stocker H, Andjelkovic M, Oldham S, Laffargue M, Wymann MP, Hemmings BA, Hafen E: Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science. 2002, 295: 2088-2091. 10.1126/science.1068094CrossRefPubMed
26.
go back to reference Cao J, Wan L, Hacker E, Dai X, Lenna S, Jimenez-Cervantes C, Wang Y, Leslie NR, Xu GX, Widlund HR, Ryu B, Alani RM, Dutton-Regester K, Goding CR, Hayward NK, Wei W, Cui R: MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol Cell. 2013, 51: 409-422. 10.1016/j.molcel.2013.08.010PubMedCentralCrossRefPubMed Cao J, Wan L, Hacker E, Dai X, Lenna S, Jimenez-Cervantes C, Wang Y, Leslie NR, Xu GX, Widlund HR, Ryu B, Alani RM, Dutton-Regester K, Goding CR, Hayward NK, Wei W, Cui R: MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol Cell. 2013, 51: 409-422. 10.1016/j.molcel.2013.08.010PubMedCentralCrossRefPubMed
27.
go back to reference Kang YH, Lee HS, Kim WH: Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest. 2002, 82: 285-291. 10.1038/labinvest.3780422CrossRefPubMed Kang YH, Lee HS, Kim WH: Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest. 2002, 82: 285-291. 10.1038/labinvest.3780422CrossRefPubMed
28.
go back to reference Wang X, Jiang X: Post-translational regulation of PTEN. Oncogene. 2008, 27: 5454-5463. 10.1038/onc.2008.242CrossRefPubMed Wang X, Jiang X: Post-translational regulation of PTEN. Oncogene. 2008, 27: 5454-5463. 10.1038/onc.2008.242CrossRefPubMed
29.
go back to reference Vasudevan KM, Gurumurthy S, Rangnekar VM: Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol. 2004, 24: 1007-1021. 10.1128/MCB.24.3.1007-1021.2004PubMedCentralCrossRefPubMed Vasudevan KM, Gurumurthy S, Rangnekar VM: Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol. 2004, 24: 1007-1021. 10.1128/MCB.24.3.1007-1021.2004PubMedCentralCrossRefPubMed
30.
go back to reference Fan Y, Yu Y, Mao R, Zhang H, Yang J: TAK1 Lys-158 but not Lys-209 is required for IL-1beta-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-kappaB activation. Cell Signal. 2011, 23: 660-665. 10.1016/j.cellsig.2010.11.017PubMedCentralCrossRefPubMed Fan Y, Yu Y, Mao R, Zhang H, Yang J: TAK1 Lys-158 but not Lys-209 is required for IL-1beta-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-kappaB activation. Cell Signal. 2011, 23: 660-665. 10.1016/j.cellsig.2010.11.017PubMedCentralCrossRefPubMed
31.
go back to reference Chen FE, Huang DB, Chen YQ, Ghosh G: Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature. 1998, 391: 410-413. 10.1038/34956CrossRefPubMed Chen FE, Huang DB, Chen YQ, Ghosh G: Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature. 1998, 391: 410-413. 10.1038/34956CrossRefPubMed
32.
go back to reference Lee YR, Yu HN, Noh EM, Youn HJ, Song EK, Han MK, Park CS, Kim BS, Park YS, Park BK, Lee SH, Kim JS: TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells. Exp Mol Med. 2007, 39: 121-127. 10.1038/emm.2007.14CrossRefPubMed Lee YR, Yu HN, Noh EM, Youn HJ, Song EK, Han MK, Park CS, Kim BS, Park YS, Park BK, Lee SH, Kim JS: TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells. Exp Mol Med. 2007, 39: 121-127. 10.1038/emm.2007.14CrossRefPubMed
33.
go back to reference Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM: Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem. 2004, 279: 4285-4291.CrossRefPubMed Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM: Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem. 2004, 279: 4285-4291.CrossRefPubMed
34.
go back to reference Yang SM, Huang C, Li XF, Yu MZ, He Y, Li J: miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 2013, 306: 162-168.CrossRefPubMed Yang SM, Huang C, Li XF, Yu MZ, He Y, Li J: miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 2013, 306: 162-168.CrossRefPubMed
35.
go back to reference Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y: MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer. 2013, 12: 30- 10.1186/1476-4598-12-30PubMedCentralCrossRefPubMed Wu W, Yang J, Feng X, Wang H, Ye S, Yang P, Tan W, Wei G, Zhou Y: MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer. 2013, 12: 30- 10.1186/1476-4598-12-30PubMedCentralCrossRefPubMed
36.
go back to reference Wang S, Liu Z, Wang L, Zhang X: NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009, 6: 327-334. 10.1038/cmi.2009.43PubMedCentralCrossRefPubMed Wang S, Liu Z, Wang L, Zhang X: NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009, 6: 327-334. 10.1038/cmi.2009.43PubMedCentralCrossRefPubMed
Metadata
Title
NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1β induction
Authors
Jun Ma
Jun Liu
Zhiming Wang
Xixi Gu
Yue Fan
Wen Zhang
Lili Xu
Jianjun Zhang
Dingfang Cai
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2014
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-13-40

Other articles of this Issue 1/2014

Molecular Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine